| 1 |
A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics |
|
|
| Rakshit K Singh, Revat J Meshram, Aakriti Tiwari |
|
| Cureus. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
GABAergic regulation of cell proliferation within the adult mouse spinal cord |
|
|
| Lauryn E. New, Yuchio Yanagawa, Glenn A. McConkey, Jim Deuchars, Susan A. Deuchars |
|
| Neuropharmacology. 2022; : 109326 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Therapeutic Properties of Highly Selective ß-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease |
|
|
| Waleed AlHabeeb, Sanaa Mrabeti, Ahmed Adel Ibrahim Abdelsalam |
|
| Cardiovascular Drugs and Therapy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Involvement of Histamine 2 Receptor in Alpha 1 Adrenoceptor Mediated Cardiac Hypertrophy and Oxidative Stress in H9c2 Cardio Myoblasts |
|
|
| Ajay Godwin Potnuri, Lingesh Allakonda, Sherin Saheera |
|
| Journal of Cardiovascular Translational Research. 2021; 14(1): 184 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
ß-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now? |
|
|
| Atul Pathak, Sanaa Mrabeti |
|
| Vascular Health and Risk Management. 2021; Volume 17: 337 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression |
|
|
| Krysten E. Ferraino, Natalie Cora, Celina M. Pollard, Anastasiya Sizova, Jennifer Maning, Anastasios Lymperopoulos |
|
| Cellular Signalling. 2021; 82: 109967 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade |
|
|
| François Moisan, Sandra Oucherif, Priscilla Kaulanjan-Checkmodine, Sorilla Prey, Benoît Rousseau, Marc Bonneu, Stéphane Claverol, Etienne Gontier, Sabrina Lacomme, Lea Dousset, Thierry Couffinhal, Jerome Toutain, Maya Loot, Muriel Cario-André, Marie-Laure Jullié, Christine Léauté-Labrèze, Alain Taieb, Hamid Reza Rezvani |
|
| Proceedings of the National Academy of Sciences. 2021; 118(7): e201869011 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Synthesis of anti-allergic drugs |
|
|
| Shiyang Zhou, Gangliang Huang |
|
| RSC Advances. 2020; 10(10): 5874 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
d Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects |
|
|
| Shigeto Hirayama , Hideaki Fujii |
|
| Current Topics in Medicinal Chemistry. 2020; 20(31): 2889 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
The antagonistic activity of H1 receptor antagonists as medicinal foods |
|
|
| Shiyang Zhou, Gangliang Huang, Guangying Chen |
|
| Trends in Food Science & Technology. 2020; 105: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Discovery of d Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice |
|
|
| Shigeto Hirayama, Takashi Iwai, Eika Higashi, Minami Nakamura, Chiharu Iwamatsu, Kennosuke Itoh, Toru Nemoto, Mitsuo Tanabe, Hideaki Fujii |
|
| ACS Chemical Neuroscience. 2019; 10(5): 2237 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Detailed insight on ß-adrenoceptors as therapeutic targets |
|
|
| Bharath Kumar Velmurugan, Rathinasamy Baskaran, Chih-Yang Huang |
|
| Biomedicine & Pharmacotherapy. 2019; 117: 109039 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Design, synthesis and biological activity of a novel ethylenediamine derivatives as H1 receptor antagonists |
|
|
| Shiyang Zhou, Gangliang Huang, Guangying Chen |
|
| Bioorganic & Medicinal Chemistry. 2019; 27(24): 115127 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
RETRACTED ARTICLE: ß2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro
|
|
|
| Jian Luo, Yuan-hua Liu, Wei Luo, Zhu Luo, Chun-tao Liu |
|
| Scientific Reports. 2017; 7(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Chronic diphenhydramine abuse and withdrawal |
|
|
| Jagroop S. Saran, Richard L. Barbano, Rachel Schult, Timothy J. Wiegand, Olga Selioutski |
|
| Neurology: Clinical Practice. 2017; 7(5): 439 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Candesartan Improves Ischemia-Induced Impairment of the Blood–Brain Barrier In Vitro |
|
|
| Gohei So,Shinsuke Nakagawa,Yoichi Morofuji,Takeshi Hiu,Kentaro Hayashi,Kunihiko Tanaka,Kazuhiko Suyama,Maria A. Deli,Izumi Nagata,Takayuki Matsuo,Masami Niwa |
|
| Cellular and Molecular Neurobiology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Pimavanserin for the treatment of Parkinsonæs disease psychosis |
|
|
| Joseph H Friedman |
|
| Expert Opinion on Pharmacotherapy. 2013; 14(14): 1969 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
